Allianz Asset Management GmbH - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q4 2021$60,000
-1.6%
16,684
-0.1%
0.00%
Q3 2021$61,000
-9.0%
16,694
+9.0%
0.00%
Q2 2021$67,000
+8.1%
15,314
+1.2%
0.00%
Q1 2021$62,000
-13.9%
15,137
-16.3%
0.00%
Q4 2020$72,000
+38.5%
18,090
-6.9%
0.00%
Q3 2020$52,000
-24.6%
19,441
-22.8%
0.00%
Q2 2020$69,000
-92.5%
25,192
-93.6%
0.00%
-100.0%
Q1 2020$923,000
-50.2%
390,907
-0.8%
0.00%
-50.0%
Q4 2019$1,853,000
+44.5%
394,158
+2.8%
0.00%
+100.0%
Q3 2019$1,282,000
-53.9%
383,406
-54.6%
0.00%
-66.7%
Q2 2019$2,780,000
+8.6%
845,103
+0.0%
0.00%0.0%
Q1 2019$2,560,000
+10.3%
844,766
-1.0%
0.00%0.0%
Q4 2018$2,320,000
-22.5%
852,933
-4.3%
0.00%0.0%
Q3 2018$2,995,000
+52.9%
891,286
+17.4%
0.00%
+50.0%
Q2 2018$1,959,000
+16.7%
759,173
-0.5%
0.00%0.0%
Q1 2018$1,679,000
+8.7%
763,011
-1.7%
0.00%
+100.0%
Q4 2017$1,545,000
-39.3%
776,204
-1.3%
0.00%
-50.0%
Q3 2017$2,547,000
+2.2%
786,240
+1.6%
0.00%0.0%
Q2 2017$2,492,000
+133.3%
773,838
+93.5%
0.00%
+100.0%
Q2 2014$1,068,000
-83.4%
400,000
-78.2%
0.00%
-87.5%
Q1 2014$6,423,000
-15.8%
1,835,234
+7.8%
0.01%
-20.0%
Q4 2013$7,630,000
+24.5%
1,703,154
+12.8%
0.01%
+25.0%
Q3 2013$6,129,000
+0.9%
1,509,626
+3.4%
0.01%
-11.1%
Q2 2013$6,074,0001,460,1550.01%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,180,0004.34%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,535,727$11,056,0003.87%
Sargent Investment Group, LLC 3,596,250$15,680,0003.72%
Rubric Capital Management LP 9,500,000$41,420,0002.61%
PERKINS CAPITAL MANAGEMENT INC 541,783$2,362,0001.34%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$8,284,0001.14%
Venator Capital Management Ltd. 709,700$3,094,0001.05%
LEVEL FOUR FINANCIAL, LLC 120,000$523,0000.22%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$875,0000.19%
Brown Advisory Securities, LLC 275,000$1,199,0000.19%
View complete list of ANTARES PHARMA INC shareholders